Article
Modular mRNA platform for <i>in vivo</i> antigen-specific immune tolerance
2026-05-21
Abstract excerpt
Immune-mediated diseases such as autoimmunity and allergy arise from dysregulated antigen-specific responses, yet current therapies largely rely on broad immunosuppression and rarely re-establish durable, antigen-selective tolerance. Here we introduce Tol-mRNA, a modular tolerogenic mRNA platform designed to deliver multiple immune-regulatory signals in vivo to program antigen-specific tolerance. Tol-mRNA co-enco...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 82f8b06c-ccdb-58fa-b505-695d27a9c56f
- DOI
- 10.64898/2026.05.18.725807
